$33M Drives Notre Dame Mission to Eradicate Malaria

Posted: Updated:
Grieco says the grant will support testing spatial repellents at a refugee setting in Uganda. (Photo: Matt Cashore, Notre Dame) Grieco says the grant will support testing spatial repellents at a refugee setting in Uganda. (Photo: Matt Cashore, Notre Dame)

A single sheet of plastic—much like a standard piece of paper—could be the missing piece to finally win the battle against mosquito-borne diseases that cripple the health of people in developing countries. Deceptively simple in appearance, the high-tech solution is a spatial repellent for mosquitos—a strategy that University of Notre Dame’s Dr. John Grieco and his wife, Dr. Nicole Achee, also a Notre Dame researcher, began 25 years ago in a tiny hut in Central America. A recent $33.7 million grant, the largest research award in the university’s history, could move their hypothesis that took shape in a hut to a respected public health intervention.

“That [dollar] value somewhat does a disservice to the overall impact that we hope to have with this product in saving lives; there’s no value you can put on that,” says Grieco, who is associate director of the university’s Eck Institute for Global Health and the project’s principal investigator. “Hopefully, [the grant] will allow us to get to those terms we’re throwing around like ‘eradication’ and ‘elimination’ for both dengue and malaria.”

Current tools that battle mosquito-borne diseases, namely bed nets and indoor residual spraying, are making headway in driving down rates of malaria and dengue, but much work remains. The World Malaria Report, published annually by the World Health Organization (WHO), estimated 219 million new cases of malaria and 435,000 deaths in 2017; dengue affects nearly 4 billion people.

While bed nets and indoor residual spraying are effective, “we may only be achieving 70 percent coverage in some villages,” says Grieco, “so how do we protect the other 30 percent?” These standard tools also may not be practical solutions in especially challenging settings, such as refugee camps that rely on tents for shelter. The $33 million grant from global health nonprofit Unitaid will fund a test site at a refugee setting in Uganda, as well as displaced populations in Mali.

Grieco likens spatial repellents to topical repellents applied to the skin; mosquitos either cannot detect the person wearing repellent, or the chemical is noxious enough that mosquitos don’t want to come toward it.

“[Spatial repellents] are the same concept, but you’re putting [the chemicals] on a surface, and you’re protecting an area, such as the interior of a home. In our case, it’s a plastic sheet that’s hung in the house—like a sheet of paper made out of clear plastic. The chemical is applied to the surface, then it’s folded and heat-sealed,” says Grieco. “When you open it, the volatile chemical is released into the air and fills the space of the house; mosquitos detect it in the air, and they won’t come in the house. It basically creates a bubble around the home, and all of the people inside are protected by this sort of chemical barrier.”

The Notre Dame team, which includes Achee, Alex Perkins, Sean Moore, Fang Liu, Neil Lobo and Jarek Nabrzyski, believes the spatial repellents will be a powerful tool in refugee settings. The grant is also funding clinical trials in Kenya and Sri Lanka.

While spatial repellents won’t replace bed nets, for example, they offer a distinct benefit by eliminating logistical hurdles.

“A bed net is a fairly large package; if you’ve got 100 or 1,000 bed nets that need to go to a village, versus 100 or 1,000 sheets of paper, the ease of transport is one advantage of this product,” says Grieco. “An individual riding a bike [is better] than using a truck or larger vehicles. We’re hoping that component will reduce delivery costs, while increasing coverage in some of these difficult locations where malaria is the most problematic.”

The effort led by Notre Dame is one of the first projects that will introduce a new tool to combat mosquito-borne diseases. The team is hopeful it will lead WHO to recommend spatial repellents—a critical endorsement needed for widespread use.

“It’s been a 25-year journey convincing people spatial repellents even exist, to recognition of them, and now, getting them out there. We’re seeing our life work come to fruition,” says Grieco. “We’ve been working around the world, and we see the damage these diseases have on day-to-day life and on people’s survival. To know that we could have an impact by saving lives and improving health in these locations is the primary benefit for us. That’s our goal.”

Unitaid brings the power of new medical discoveries to the people who most need them and helps set the stage for large-scale introduction of new health products by collaborating with governments and partners such as PEPFAR, the Global Fund and WHO. Unitaid invests in new ways to prevent, diagnose and treat diseases including HIV/AIDS, hepatitis C, tuberculosis and malaria more quickly, affordably and effectively.

Grieco says private industry wants to move novel repellents to market faster, but new tools must first prove their efficacy.
Grieco says, while current mosquito control tools are very productive, their impact has plateaued.
  • Perspectives

    • Take Time to Face Reality

      When is the last time that you as a business owner truly stopped for 30 minutes or an hour and truly took some quiet time to reflect on your business? Like most owners, it’s probably been quite some time. We all get busy doing things, working hard, taking care of customers, running the business. But if we don’t take some time each day, week, month or quarter to slow down, we are setting ourselves up for failure. Business leaders and owners need the time to slow down to...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • (Image provided by the Capital Improvement Board.)

      Indy Alters Plans for Downtown Hotels

      The city of Indianapolis has announced plans to change the framework for a major project in downtown Indy that has sparked controversy. The $120 million project, announced in October 2018, calls for an expansion of the Indiana Convention Center and two new hotels at Pan Am Plaza, which would add about 1,400 rooms. The project has drawn criticism from a group of hoteliers, who have expressed concern of a potential oversaturation in downtown Indy. Indianapolis Mayor Joe Hogsett issued...

    • (Photo Courtesy: Roche Diagnostics)

      Roche VP on List of Influential Women Executives

      An executive with Roche Diagnostics has joined an exclusive list of prominent and influential women, including Oprah Winfrey and Serena Williams.  Cindy Carlisle, Vice President of Human Resources at Roche Indy, was named to Savoy Magazine’s 2019 Most Influential Women in Corporate America. 

    • Shelly Timmons

      IU Health Names New Leader of Neurosurgery

      The Indiana University School of Medicine and IU Health Physicians have named Shelly Timmons to lead the department of neurosurgery. She previously served at Penn State Health Milton S. Hershey Medical Center as vice chair for administration in the department of neurosurgery and director of neurotrauma.  

    • Bank of America Merrill Lynch Adds Mar

      Bank of America Merrill Lynch has named Lucia Mar as senior vice president and the newly created position of Indiana market executive for Global Commercial Banking. She most recently served as market manager for the Greater Tennessee market in business banking. Prior to becoming a market manager, Mar was a senior relationship manager with the healthcare and institutions team.

    • Elanco is headquartered in Greenfield.

      Elanco Finishes Deal on Pet Therapeutics Purchase

      Greenfield-based Elanco Animal Health Inc.(NYSE: ELAN) completed its purchase Thursday of Aratana Therapeutics (Nasdaq: PETX), a pet therapeutics company located near Kansas City. As Inside INdiana Business first reported Tuesday Aratana shareholders voted overwhelmingly in favor of the $245 million deal.